Candel Therapeutics IncNASDAQ:CADL
- LAST PRICE5.0400
- TODAY'S CHANGE (%)0.9050 (21.8863%)
- Bid / Lots5.0500/ 10
- Ask / Lots5.1700/ 48
- Open / Previous Close4.1900 / 4.1350
- Day Range
- 52 Week Range
- Volume2,312,608
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CADL |
|---|---|---|
| 09:32 ET | 5419 | 4.235 |
| 09:33 ET | 3093 | 4.4275 |
| 09:35 ET | 4054 | 4.435 |
| 09:37 ET | 11934 | 4.562 |
| 09:39 ET | 8311 | 4.59 |
| 09:42 ET | 12375 | 4.59 |
| 09:44 ET | 4399 | 4.56 |
| 09:46 ET | 16450 | 4.5501 |
| 09:48 ET | 14041 | 4.5 |
| 09:50 ET | 15987 | 4.495 |
| 09:51 ET | 12876 | 4.5465 |
| 09:53 ET | 12837 | 4.63 |
| 09:55 ET | 25930 | 4.71 |
| 09:57 ET | 17460 | 4.6714 |
| 10:00 ET | 9805 | 4.6727 |
| 10:02 ET | 1932 | 4.66 |
| 10:04 ET | 3010 | 4.65 |
| 10:06 ET | 4493 | 4.6 |
| 10:08 ET | 5974 | 4.67 |
| 10:09 ET | 1200 | 4.675 |
| 10:11 ET | 9092 | 4.6501 |
| 10:13 ET | 3760 | 4.63 |
| 10:15 ET | 3352 | 4.66 |
| 10:18 ET | 7375 | 4.715 |
| 10:20 ET | 2200 | 4.7 |
| 10:22 ET | 3000 | 4.72 |
| 10:24 ET | 13953 | 4.74 |
| 10:26 ET | 18310 | 4.79 |
| 10:27 ET | 19930 | 4.81 |
| 10:29 ET | 4544 | 4.76 |
| 10:31 ET | 15680 | 4.8 |
| 10:33 ET | 6408 | 4.79 |
| 10:36 ET | 9907 | 4.7601 |
| 10:38 ET | 9773 | 4.8483 |
| 10:40 ET | 15960 | 4.81 |
| 10:42 ET | 8195 | 4.85 |
| 10:44 ET | 15399 | 4.935 |
| 10:45 ET | 24102 | 4.89 |
| 10:47 ET | 14130 | 4.83 |
| 10:49 ET | 7118 | 4.7817 |
| 10:51 ET | 9290 | 4.8399 |
| 10:54 ET | 19843 | 4.875 |
| 10:56 ET | 10600 | 4.89 |
| 10:58 ET | 5416 | 4.9017 |
| 11:00 ET | 16600 | 4.9 |
| 11:02 ET | 300 | 4.89 |
| 11:03 ET | 9041 | 4.88 |
| 11:05 ET | 8489 | 4.8 |
| 11:07 ET | 7873 | 4.76 |
| 11:09 ET | 2765 | 4.815 |
| 11:12 ET | 2220 | 4.8 |
| 11:14 ET | 6267 | 4.8197 |
| 11:16 ET | 14676 | 4.8194 |
| 11:18 ET | 8091 | 4.93 |
| 11:20 ET | 4100 | 4.9 |
| 11:21 ET | 26452 | 5.025 |
| 11:23 ET | 1400 | 5.03 |
| 11:25 ET | 27447 | 5.05 |
| 11:27 ET | 4125 | 5.07 |
| 11:30 ET | 1159 | 5.04 |
| 11:32 ET | 755 | 5.0433 |
| 11:34 ET | 18946 | 5.09 |
| 11:36 ET | 5351 | 5.07 |
| 11:38 ET | 14087 | 5.14 |
| 11:39 ET | 4287 | 5.095 |
| 11:41 ET | 5696 | 5.0518 |
| 11:43 ET | 1805 | 5.075 |
| 11:45 ET | 3125 | 5.07 |
| 11:48 ET | 1496 | 5.07 |
| 11:50 ET | 3269 | 5.09 |
| 11:52 ET | 408 | 5.12 |
| 11:54 ET | 8936 | 5.085 |
| 11:56 ET | 14826 | 5.12 |
| 11:57 ET | 5895 | 5.1 |
| 11:59 ET | 1564 | 5.085 |
| 12:01 ET | 1275 | 5.08 |
| 12:03 ET | 6296 | 5.07 |
| 12:06 ET | 300 | 5.07 |
| 12:08 ET | 990 | 5.07 |
| 12:10 ET | 16157 | 5.07 |
| 12:12 ET | 7614 | 5.08 |
| 12:14 ET | 707 | 5.0418 |
| 12:15 ET | 150 | 5.0751 |
| 12:17 ET | 3820 | 5.075 |
| 12:19 ET | 3440 | 5.065 |
| 12:21 ET | 100 | 5.06 |
| 12:24 ET | 900 | 5.085 |
| 12:26 ET | 312 | 5.075 |
| 12:28 ET | 5776 | 5.1099 |
| 12:30 ET | 6994 | 5.104 |
| 12:32 ET | 17444 | 5.195 |
| 12:33 ET | 11114 | 5.22 |
| 12:35 ET | 24111 | 5.2481 |
| 12:37 ET | 19773 | 5.1919 |
| 12:39 ET | 26639 | 5.33 |
| 12:42 ET | 16386 | 5.2 |
| 12:44 ET | 20240 | 5.2885 |
| 12:46 ET | 17115 | 5.2817 |
| 12:48 ET | 15802 | 5.35 |
| 12:50 ET | 40554 | 5.355 |
| 12:51 ET | 15933 | 5.4 |
| 12:53 ET | 20012 | 5.4 |
| 12:55 ET | 21347 | 5.475 |
| 12:57 ET | 27155 | 5.5046 |
| 01:00 ET | 43966 | 5.524892 |
| 01:02 ET | 20033 | 5.48 |
| 01:04 ET | 37985 | 5.3203 |
| 01:06 ET | 36383 | 5.31 |
| 01:08 ET | 7530 | 5.2793 |
| 01:09 ET | 8450 | 5.25 |
| 01:11 ET | 7490 | 5.27 |
| 01:13 ET | 2489 | 5.2401 |
| 01:15 ET | 9040 | 5.23 |
| 01:18 ET | 2390 | 5.2179 |
| 01:20 ET | 632 | 5.225 |
| 01:22 ET | 47460 | 5.08 |
| 01:24 ET | 21068 | 5.18 |
| 01:26 ET | 17633 | 5.11 |
| 01:27 ET | 20772 | 4.96 |
| 01:29 ET | 15755 | 5 |
| 01:31 ET | 13394 | 5.02 |
| 01:33 ET | 6125 | 5.1 |
| 01:36 ET | 1970 | 5.09 |
| 01:38 ET | 2051 | 5.1 |
| 01:40 ET | 3440 | 5.115 |
| 01:42 ET | 6205 | 5.075 |
| 01:44 ET | 5987 | 5.02 |
| 01:45 ET | 26660 | 5.08 |
| 01:47 ET | 17351 | 5.065 |
| 01:49 ET | 3253 | 5.05 |
| 01:51 ET | 3355 | 5.0618 |
| 01:54 ET | 4799 | 5.06 |
| 01:56 ET | 2112 | 5.0724 |
| 01:58 ET | 1431 | 5.075 |
| 02:00 ET | 5873 | 5.0682 |
| 02:02 ET | 1384 | 5.03 |
| 02:03 ET | 1944 | 5.067 |
| 02:05 ET | 2291 | 5.03 |
| 02:07 ET | 11230 | 5.055 |
| 02:09 ET | 8399 | 5.06 |
| 02:12 ET | 18863 | 5.153453 |
| 02:16 ET | 4835 | 5.095 |
| 02:18 ET | 1050 | 5.07 |
| 02:20 ET | 2824 | 5.065 |
| 02:21 ET | 592 | 5.06 |
| 02:23 ET | 9397 | 5.03 |
| 02:25 ET | 5170 | 5.02 |
| 02:27 ET | 11803 | 5.03 |
| 02:30 ET | 4997 | 5.04 |
| 02:32 ET | 3199 | 5.04 |
| 02:34 ET | 5715 | 4.98 |
| 02:36 ET | 6001 | 5.01 |
| 02:38 ET | 7625 | 5.02 |
| 02:39 ET | 4288 | 5.07 |
| 02:41 ET | 11056 | 5.03 |
| 02:43 ET | 6454 | 5.06 |
| 02:45 ET | 9082 | 5.06 |
| 02:48 ET | 2856 | 5.0884 |
| 02:50 ET | 4878 | 5.0435 |
| 02:52 ET | 4245 | 5.13 |
| 02:54 ET | 2575 | 5.126464 |
| 02:56 ET | 1821 | 5.115 |
| 02:57 ET | 1600 | 5.0989 |
| 02:59 ET | 5900 | 5.0912 |
| 03:01 ET | 2178 | 5.05 |
| 03:03 ET | 455 | 5.08 |
| 03:06 ET | 13420 | 5.05 |
| 03:08 ET | 1597 | 5.05 |
| 03:10 ET | 2761 | 5.05 |
| 03:12 ET | 8896 | 5.03 |
| 03:14 ET | 16534 | 4.978 |
| 03:15 ET | 10056 | 4.985 |
| 03:17 ET | 5200 | 4.99 |
| 03:19 ET | 19832 | 5.0129 |
| 03:21 ET | 16975 | 4.99 |
| 03:24 ET | 10300 | 5.005 |
| 03:26 ET | 5907 | 5.005 |
| 03:28 ET | 13628 | 5.03 |
| 03:30 ET | 2476 | 5.07 |
| 03:32 ET | 2145 | 5.08 |
| 03:33 ET | 700 | 5.07 |
| 03:35 ET | 2301 | 5.07 |
| 03:37 ET | 3995 | 5.08 |
| 03:39 ET | 3548 | 5.0504 |
| 03:42 ET | 6950 | 5.07 |
| 03:44 ET | 3995 | 5.075 |
| 03:46 ET | 6331 | 5.05 |
| 03:48 ET | 14084 | 5.04 |
| 03:50 ET | 18929 | 5.05 |
| 03:51 ET | 4932 | 5.03 |
| 03:53 ET | 7824 | 5.04 |
| 03:55 ET | 27589 | 5.045 |
| 03:57 ET | 41653 | 5.043 |
| 04:00 ET | 163109 | 5.04 |
Nov 18, 2024
DJ Candel Therapeutics Price Target Maintained With a $11.00/Share by HC Wainwright & Co., from 8:00AM ET on Monday Nov 18, 2024 by Dow Jones
8:00AM ET on Monday Nov 18, 2024 by Dow Jones
Nov 14, 2024
Candel Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights, from 8:00AM ET on Thursday Nov 14, 2024 by Dow Jones
8:00AM ET on Thursday Nov 14, 2024 by Dow JonesPress Release: Candel Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights, from 8:00AM ET on Thursday Nov 14, 2024 by Dow Jones
8:00AM ET on Thursday Nov 14, 2024 by Dow Jones
Nov 7, 2024
Candel Therapeutics to Present at Jefferies London Healthcare Conference 2024, from 8:00AM ET on Thursday Nov 07, 2024 by Dow Jones
8:00AM ET on Thursday Nov 07, 2024 by Dow Jones
Nov 5, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Candel Therapeutics Inc | 132.7M | -2.9x | --- |
Inhibikase Therapeutics Inc | 135.1M | -0.8x | --- |
Black Diamond Therapeutics Inc | 137.5M | -1.9x | --- |
InflaRx NV | 121.3M | -2.1x | --- |
Acumen Pharmaceuticals Inc | 138.8M | -1.7x | --- |
Skye Bioscience Inc | 126.5M | -4.9x | --- |
Company Information
Candel Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing off-the-shelf multimodal biological immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The Company has established two clinical-stage multimodal biological immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) gene constructs, respectively. CAN-2409 is the lead product candidate from the adenovirus platform and is in ongoing clinical trials in non-small cell lung cancer (NSCLC), borderline resectable pancreatic cancer, and localized, non-metastatic prostate cancer. CAN-3110 is the lead product candidate from the HSV platform and is in an ongoing investigator-sponsored phase I clinical trial in recurrent high-grade glioma (HGG). Its enLIGHTEN Discovery Platform leverages human biology and advanced analytics to create new viral immunotherapies for solid tumors.
Contact Information
- Headquarters
- 117 Kendrick Street,, Suite 450NEEDHAM, MA, United States 02494
- Phone
- 617-916-5445
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Paul Manning
- President, Chief Executive Officer, Director
- Paul Tak
- Interim Chief Financial Officer
- Charles Schoch
- Chief Scientific Officer
- Francesca Barone
- Chief Medical Officer
- W. Garrett Nichols
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $132.7M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 32.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.96 |
EPS | $-1.74 |
Book Value | $0.44 |
P/E Ratio | -2.9x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
